Talent RiskLive job-cut intelligence on the biggest employers

← Talent Risk

Genentech

QuietGENENPharma & healthcare · HQ US · Updated 1 November 2026

No job cuts reported at Genentech in the last 90 days. The last was on 1 July: Genentech filed a WARN notice on 2026-07-01 for a permanent layoff of 103 employees at its San Mateo County, CA facility, effective 2026-07-29.

244Job cuts announced · 12 months
1.6%Of its ≈14,815 staff
2Rounds of cuts · 12 months
NoSays AI is a reason

The last 12 months

DecJanFebMarAprMayJunJulAugSeptOctNov2026-07-01: Genentech filed a WARN notice on 2026-07-01 for a permanent layoff of 103 employees at its San Mateo County, CA facility, effective 2026-07-29.2026-02-04: Genentech filed a WARN notice for a permanent layoff of 141 employees at its San Mateo County, CA facility, effective 2025-08-18.141103
CutsBuyouts, plans and signsHiringBigger mark = more jobs named

No cuts this quarter. No cuts announced in the last 90 days.

Which jobs, and where

Countries named
US

How it compares in pharma & healthcare

  1. GSK2.7% of staff
  2. Genentech1.6% of staff
  3. Gilead Sciences1.2% of staff
  4. Novartis0.7% of staff
  5. Walgreens0.2% of staff
  6. Johnson & Johnson0.1% of staff

Job cuts announced in the last 12 months, as a share of each employer’s workforce.

The evidence

Every report behind the rating, newest first, with its source. How we decide

Nothing from Genentech, a formal notice or a named outlet about its workforce in the last 90 days.

Earlier on the record (2 events, up to a year)
  1. 1 July 2026 · Cuts announced · 103 jobs

    Genentech filed a WARN notice on 2026-07-01 for a permanent layoff of 103 employees at its San Mateo County, CA facility, effective 2026-07-29.

    Tier 1 · CompanyWARN notice (CA)
  2. 4 February 2026 · Cuts announced · 141 jobs

    Genentech filed a WARN notice for a permanent layoff of 141 employees at its San Mateo County, CA facility, effective 2025-08-18.

    Tier 1 · CompanyWARN notice (CA)

Right of reply

Every fact above comes from Genentech’s own statements or from named reporting, so no comment was sought before publication. Genentech can correct the record at any time; anything approved is published here in full.

Correct the record →

This is the Editor’s opinion based on the sources listed.